A scalable application of Artificial Intelligence-Driven Insulin Titration Program to transform Type 2 Diabetes Management
Article in Diabetes Technology & Therapeutics (March 2024)
The most recent citing publications are shown below. View all 624 publications that cite this research output on Dimensions.
Factors and economic burden of non-severe hypoglycemia among insulin-treated type 2 diabetes patients: a cross-sectional study
Article in Current Medical Research and Opinion (February 2024)
Tirzepatide 10 and 15 mg vs semaglutide 2.0 mg: A long-term cost-effectiveness analysis in patients with type 2 diabetes in the United States.
Article in Journal of Managed Care & Specialty Pharmacy (February 2024)